English
English 简体中文
0760-89920979
0760-89920979
16984638634831788
News
Home> News /
05-30
2025
594bf575b1447205f44dc9f5cc5b7f7(1)
The Fifth Meeting of the First Session of the Board of Directors & 2024 Annual Shareholders' Meeting of Rabpharma Successfully Concluded​​
View More>
03-01
2025
17508328469373239(1)
​Phase II Clinical Trial of RAB001 Officially Launched at Beijing Jishuitan Hospital and The Third Affiliated Hospital of Guangzhou University of Chinese Medicine!​​
View More>
01-20
2025
17508326489335721(1)
Phase II Clinical Trial of RAB001 Officially Launched at Peking University Third Hospital!
View More>
12-25
2024
17504042123998489(1)
First Subject Enrolled in Phase II Clinical Trial of World's First Osteonecrosis Drug RAB001!​​
View More>
11-27
2024
17504036252275369(1)
​Rabpharma Wins Silver Award at Greater Bay Area Postdoctoral Innovation Competition!​​
View More>
12345
0760-89920979
info@rabpharma.com